These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35813625)

  • 1. Associations of Uric Acid With Liver Steatosis and Fibrosis Applying Vibration Controlled Transient Elastography in the United States: A Nationwide Cross-Section Study.
    Duan H; Zhang R; Chen X; Yu G; Song C; Jiang Y; He Y; Wan H; Shen J
    Front Endocrinol (Lausanne); 2022; 13():930224. PubMed ID: 35813625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marijuana use is inversely associated with liver steatosis detected by transient elastography in the general United States population in NHANES 2017-2018: A cross-sectional study.
    Du R; Tang XY; Yang C; Gao WH; Gao SJ; Xiang HJ; Yang L
    PLoS One; 2023; 18(5):e0284859. PubMed ID: 37200309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure, glycemic status and advanced liver fibrosis assessed by transient elastography in the general United States population.
    Ciardullo S; Monti T; Grassi G; Mancia G; Perseghin G
    J Hypertens; 2021 Aug; 39(8):1621-1627. PubMed ID: 33657584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population.
    Ciardullo S; Ballabeni C; Trevisan R; Perseghin G
    Dig Liver Dis; 2021 Jul; 53(7):866-872. PubMed ID: 33685807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with significant liver steatosis and fibrosis as assessed by transient elastography in patients with one or more components of the metabolic syndrome.
    Mikolasevic I; Milic S; Orlic L; Stimac D; Franjic N; Targher G
    J Diabetes Complications; 2016; 30(7):1347-53. PubMed ID: 27324703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between dietary flavonoid intake with hepatic steatosis and fibrosis quantified by VCTE: Evidence from NHANES and FNDDS.
    Xie R; Zhang Y
    Nutr Metab Cardiovasc Dis; 2023 Jun; 33(6):1179-1189. PubMed ID: 36964061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between hypertension and the prevalence of liver steatosis and fibrosis.
    Fu H; Yu H; Zhao Y; Chen J; Liu Z
    BMC Endocr Disord; 2023 Apr; 23(1):85. PubMed ID: 37081417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALT poorly predicts Nonalcoholic Fatty Liver Disease (NAFLD) and liver fibrosis as determined by vibration-controlled transient elastography in adult National Health and Nutrition Examination Survey 2017-2018.
    Condon S; Hu H; Kong M; Cave MC; McClain CJ
    Am J Med Sci; 2024 May; 367(5):310-322. PubMed ID: 38307172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between hepatic steatosis and fibrosis and arthritis among US adults: A population-based study.
    Lu Z; Wu S; Feng E; Chen X; Chen J; Lin F
    Clinics (Sao Paulo); 2024; 79():100378. PubMed ID: 38875754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017-2018.
    Zhang X; Heredia NI; Balakrishnan M; Thrift AP
    PLoS One; 2021; 16(6):e0252164. PubMed ID: 34081733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
    Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of Fibroscan in Assessment of Hepatic Steatosis and Fibrosis in Obese Patients: Report From a General Internal Medicine Clinic.
    Avcu A; Kaya E; Yilmaz Y
    Turk J Gastroenterol; 2021 May; 32(5):466-472. PubMed ID: 34231477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between weight-adjusted-waist index with hepatic steatosis and liver fibrosis: a nationally representative cross-sectional study from NHANES 2017 to 2020.
    Shen Y; Wu Y; Fu M; Zhu K; Wang J
    Front Endocrinol (Lausanne); 2023; 14():1159055. PubMed ID: 37274346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of liver stiffness and controlled attenuation parameter measured by transient elastography with diabetes mellitus in patients with chronic liver disease.
    Ahn JM; Paik YH; Kim SH; Lee JH; Cho JY; Sohn W; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    J Korean Med Sci; 2014 Aug; 29(8):1113-9. PubMed ID: 25120322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes.
    Ciardullo S; Monti T; Perseghin G
    Diabetes Care; 2021 Feb; 44(2):519-525. PubMed ID: 33303638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAFLD and Liver Fibrosis Are Not Associated With Reduced Femoral Bone Mineral Density in the General US Population.
    Ciardullo S; Muraca E; Zerbini F; Manzoni G; Perseghin G
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e2856-e2865. PubMed ID: 33878156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population.
    Ciardullo S; Cannistraci R; Mazzetti S; Mortara A; Perseghin G
    Front Endocrinol (Lausanne); 2021; 12():711484. PubMed ID: 34381424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes.
    Ciardullo S; Perseghin G
    Metabolism; 2021 Aug; 121():154752. PubMed ID: 33716004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic dysfunction-associated steatotic liver disease-related hepatic fibrosis increases risk of insulin resistance, type 2 diabetes, and chronic kidney disease.
    Zhang W; Song WJ; Chen W; Pan Z; Zhang J; Fan L; Li J
    Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):802-810. PubMed ID: 38526946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of Serum Iron Status with MAFLD and Liver Fibrosis in the USA: a Nationwide Cross-Section Study.
    Yu G; Liu L; Qin T; Luo Y; Song C; Chen X; Duan H; Jiang Y; Zeng H; Wan H; Shen J
    Biol Trace Elem Res; 2024 Jan; 202(1):87-98. PubMed ID: 37079265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.